Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure
LB Arendse, AHJ Danser, M Poglitsch, RM Touyz… - Pharmacological …, 2019 - ASPET
Despite the success of renin-angiotensin system (RAS) blockade by angiotensin-converting
enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT1R) blockers, current …
enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT1R) blockers, current …
Angiotensin‐converting enzyme inhibitor–induced angioedema: a review of the literature
T Brown, J Gonzalez… - The Journal of Clinical …, 2017 - Wiley Online Library
According to the National Health and Nutrition Examination Survey 2012, one third of
antihypertensive prescriptions in the United States in the past decade were for angiotensin …
antihypertensive prescriptions in the United States in the past decade were for angiotensin …
The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …
appropriate therapy are essential. This update and revision of the global guideline for HAE …
[HTML][HTML] Coronary artery disease
RD Shahjehan, BS Bhutta - 2020 - europepmc.org
Coronary Artery Disease - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
Bradykinin metabolism and drug-induced angioedema
S Smolinska, D Antolín-Amérigo… - International Journal of …, 2023 - mdpi.com
Bradykinin (BK) metabolism and its receptors play a central role in drug-induced
angioedema (AE) without urticaria through increased vascular permeability. Many …
angioedema (AE) without urticaria through increased vascular permeability. Many …
ACE inhibitor-mediated angioedema
V Montinaro, M Cicardi - International Immunopharmacology, 2020 - Elsevier
Angioedema (AE) occurring during ACE inhibitor therapy (ACEi-AE) is a rare complication
involving between 0.1 and 0.7% of treated patients. AE can also complicate other …
involving between 0.1 and 0.7% of treated patients. AE can also complicate other …
[HTML][HTML] Evaluation and management of angioedema in the emergency department
BJ Long, A Koyfman, M Gottlieb - Western Journal of Emergency …, 2019 - ncbi.nlm.nih.gov
Angioedema is defined by non-dependent, non-pitting edema that affects several different
sites and is potentially life-threatening due to laryngeal edema. This narrative review …
sites and is potentially life-threatening due to laryngeal edema. This narrative review …
Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment
F Depetri, A Tedeschi, M Cugno - European journal of internal medicine, 2019 - Elsevier
Angioedema is a self-limiting edema of the subcutaneous or submucosal tissues due to
localised increase of microvascular permeability whose mediator may be histamine or …
localised increase of microvascular permeability whose mediator may be histamine or …
Drug hypersensitivity reactions
MS Dykewicz, JK Lam - Medical Clinics, 2020 - medical.theclinics.com
Adverse drug reactions (ADRs) are defined as any noxious and unintended response to a
drug. ADRs may be predictable, based on known pharmacologic properties of a drug, or …
drug. ADRs may be predictable, based on known pharmacologic properties of a drug, or …
A systematic review of molecular imaging agents targeting bradykinin B1 and B2 receptors
Kinins, bradykinin and kallidin are vasoactive peptides that signal through the bradykinin B1
and B2 receptors (B1R and B2R). B2R is constitutively expressed in healthy tissues and …
and B2 receptors (B1R and B2R). B2R is constitutively expressed in healthy tissues and …